Advertisement

Regulation of Secretion in Human Basophils

  • Donald MacGlashanJr.
Chapter

Abstract

In the long history of research on allergic disease, it has been appreciated for some time that 1 the mast cell is involved in its genesis. Only more recently has the role of the human basophil been appreciated. The basophil has manysimilarities to the mast cell, possessing histamine-containing granules that are secreted when surface-bound IgE, bound to the same high-affinity receptor found on mast cells, is aggregated by antigens. However, while having these characteristics and sometimes serving as a surrogate to the mast cell because of these similarities, the basophil is a mobile leukocyte and its actual role in the progression of an allergic response has only recently been examined in some detail.1–4

Keywords

Mast Cell Histamine Release Human Basophil FCeRI Expression Basophil Response 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bascom R, Wachs M, Naclerio RM, Pipkorn U, Galli SJ, Lichtenstein LM. Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. J Allergy Clin Immunol 1988;81:580–589.PubMedGoogle Scholar
  2. 2.
    Iliopoulos O, Baroody F, Naclerio RM, Bochner BS, Kagey-Sobotka A, Lichtenstein LM. Histamine containing cells obtained from the nose hours after antigen challenge have functions and phenotypic characteristics of basophils. J Immunol 1992;148:2223–2228.PubMedGoogle Scholar
  3. 3.
    Guo CB, Liu MC, Galli SJ, Bochner BS, Kagey-Sobotka A, Lichtenstein LM. Identification of IgE bearing cells in the late response to antigen in the lung as basophils. Am J Respir Cell Mol Biol 1993;10:384–390.Google Scholar
  4. 4.
    Irani AA, Huang C, Zweiman B, Schwartz LB. Immunohistochemical detection of basophil infiltration in the skin during the IgE-mediated late phase reaction. J Allergy Clin Immunol 1997;99:S92.Google Scholar
  5. 5.
    MacGlashan DW Jr, Peters SP, Warner J, Lichtenstein LM. Characteristics of human basophil sulfidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimeric cross-links. J Immunol 1986;136:2231–2239.PubMedGoogle Scholar
  6. 6.
    Warner JA, Freeland HS, MacGlashan DW Jr, Lichtenstein LM, Peters SP. Purified human basophils do not generate LTB4. Biochem Pharmacol 1987;36:3195–3199.PubMedGoogle Scholar
  7. 7.
    Warner JA, Peters SP, Lichtenstein LM, et al. Differential release of mediators from human basophils: differences in arachidonic acid metabolism following activation by unrelated stimuli. J Leukocyte Biol 1989;45:558–571.PubMedGoogle Scholar
  8. 8.
    Lewis RA, Holgate ST, Roberts LJ, Oates JA, Austen KF. Preferential generation of prostaglandin D2 by rat and human mast cells. Kroc Found Symp 1981;14:239–254.Google Scholar
  9. 9.
    Peters SP, MacGlashan DW Jr, Schulman ES, et al. Arachidonic acid metabolism in purified human lung mast cells. J Immunol 1984;132:1972–1979.PubMedGoogle Scholar
  10. 10.
    Brunner T, Heusser CH, Dahinden CA. Human peripheral blood basophils primed by interleukin-3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J Exp Med 1993;177:605–611.PubMedGoogle Scholar
  11. 11.
    MacGlashan DW Jr, White JM, Huang SK, Ono SJ, Schroeder J, Lichtenstein LM. Secretion of interleukin-4 from human basophils: the relationship between IL-4 mRNA and protein in resting and stimulated basophils. J Immunol 1994;152:3006–3016.PubMedGoogle Scholar
  12. 12.
    Schroeder JT, MacGlashan DW Jr, Kagey-Sobotka A, White JM, Lichtenstein LM. The IgE-dependent IL-4 secretion by human basophils: the relationship between cytokine production and histamine release in mixed leukocyte cultures. J Immunol 1994;153:1808–1817.PubMedGoogle Scholar
  13. 13.
    Li H, Sim TC, Alam R. IL-13 released by and localized in human basophils. J Immunol 1996;156:4833–4838.PubMedGoogle Scholar
  14. 14.
    Li H, Sim TC, Grant JA, Alam R. The production of macrophage inflammatory protein-1 alpha by human basophils. J Immunol 1996;157:1207–1212.PubMedGoogle Scholar
  15. 15.
    MacGlashan DW Jr. Graded changes in the response of individual human basophils to stimulation: distributional behavior of events temporally coincident with degranulation. J Leukocyte Biol 1995;58:177–188.PubMedGoogle Scholar
  16. 16.
    Dvorak AM. Basophils and mast cells: piecemeal degranulation in situ and ex vivo: a possible mechanism for cytokine-induced function in disease. In: Coffey RG, ed. Granulocyte Responses to Cytokines. New York: Marcel Dekker, 1992.Google Scholar
  17. 17.
    Dvorak AMJ, Warner JA, Kissell S, Lichtenstein LM, MacGlashan DW Jr. F-met peptide-induced degranulation of human basophils. Lab Invest 1991;64:234–253.PubMedGoogle Scholar
  18. 18.
    Dvorak AM, Morgan ES, Lichtenstein LM, MacGlashan DW Jr. Activated human basophils contain histamine in cytoplasmic vesicles. Int Arch Allergy Immunol 1994;105:8–11.PubMedGoogle Scholar
  19. 19.
    Dvorak AM, MacGlashan DW Jr, Morgan ES, Lichtenstein LM. Histamine distribution in human basophil secretory granules undergoing FMLP-stimulated secretion and recovery. Blood 1995;86:3560–3566.PubMedGoogle Scholar
  20. 20.
    Dvorak AM, Ackerman SJ, Letourneau L, Morgan ES, Lichtenstein LM, MacGlashan DW Jr. Vesicular transport of Charcot-Leydon crystal protein in tumor-promoting phorbolester stimulated human basophils. Lab Invest 1996;74:967–974.PubMedGoogle Scholar
  21. 21.
    Dvorak AM, Newball HH, Dvorak HF, Lichtenstein LM. Antigen-induced IgE-mediated degranulation of human basophils. Lab Invest 1980;43:126–139.PubMedGoogle Scholar
  22. 22.
    Marone G, Kagey SA, Lichtenstein LM. Effects of arachidonic acid and its metabolites on antigen-induced histamine release from human basophils in vitro. J Immunol 1979;123:1669–1677.PubMedGoogle Scholar
  23. 23.
    Sobotka AK, Marone G, Lichtenstein LM. Indomethacin, arachidonic acid metabolism and basophil histamine release. Monogr Allergy 1979;14:285–287.PubMedGoogle Scholar
  24. 24.
    Kurimoto Y, de Weck LA, Dahinden CA. Interleukin 3-dependent mediator release in basophils triggered by C5a. J Exp Med 1989;170:467–479.PubMedGoogle Scholar
  25. 25.
    MacGlashan DW Jr, Warner JA. Stimulus-dependent leukotriene release from human basophils: a comparative study of C5a and Fmet-leu-phe. J Leukocyte Biol 1991;49:29–40.PubMedGoogle Scholar
  26. 26.
    Ochensberger BS, Rihs S, Brunner T, Dahinden CA. IgE-independent interleukin-4 expression and induction of a late phase of leukotriene C4 formation in human blood basophils. Blood 1995;86:4039–4049.PubMedGoogle Scholar
  27. 27.
    MacGlashan DW Jr, Hubbard WC. Interleukin-3 alters free arachidonic acid generation in C5a-stimulated human basophils. J Immunol 1993;151:6358–6369.PubMedGoogle Scholar
  28. 28.
    Lichtenstein LM, MacGlashan DW Jr. The concept of basophil releasability. J Allergy Clin Immunol 1986;77:291–294.PubMedGoogle Scholar
  29. 29.
    Conroy MC, Adkinson NFJ, Lichtenstein LM. Measurement of IgE on human basophils: relation to serum IgE and anti-IgE-induced histamine release. J Immunol 1977;118:1317–1321.PubMedGoogle Scholar
  30. 30.
    MacGlashan DW Jr. Releasability of human basophils: cellular sensitivity and maximal histamine release are independent variables. J Allergy Clin Immunol 1993;91:605–615.PubMedGoogle Scholar
  31. 31.
    Nguyen KL, Gillis S, MacGlashan DW Jr. A comparative study of releasing and nonreleasing human basophils: nonreleasing basophils lack an early component of the signal transduction pathway that follows IgE cross-linking. J Allergy Clin Immunol 1990;85:1020–1029.PubMedGoogle Scholar
  32. 32.
    Knol EF, Mul FP, Kuijpers TW, Verhoeven AJ, Roos D. Intracellular events in anti-IgE nonreleasing human basophils. J Allergy Clin Immunol 1992;90:92–103.PubMedGoogle Scholar
  33. 33.
    Warner JA, MacGlashan DW Jr. Signal transduction events in human basophils—a comparative study of the role of protein kinase-C in basophils activated by anti-IgE antibody and formyl-methionyl-leucyl-phenylalanine. J Immunol 1990;145:1897–1905.PubMedGoogle Scholar
  34. 34.
    Miller L, Blank U, Metzger H, Kinet JP. Expression of high-affinity binding of human immunoglobulin E by transfected cells. Science 1989;244:334–337.PubMedGoogle Scholar
  35. 35.
    Lin S, Cicaia C, Scharenberg AM, Kinet JP. The FcεRIb subunit functions as an amplifier of FcεRIg-mediated cell activation signals. Cell 1996;85:985–995.PubMedGoogle Scholar
  36. 36.
    Schleimer RP, Gillespie E, Daiuta R, Lichtenstein LM. Release of histamine from human leukocytes stimulated with the tumor-promoting phorbol diesters. II. Interaction with other stimuli. J Immunol 1982;128:136–140.PubMedGoogle Scholar
  37. 37.
    Warner J, MacGlashan DW Jr. Persistence of early crosslink-dependent signal transduction events in human basophils after desensitization. Immunol Lett 1988;18:129–137.PubMedGoogle Scholar
  38. 38.
    Lichtenstein LM, De Bernardo R. IgE mediated histamine release: in vitro separation into two phases. Int Arch Allergy Appl Immunol 1971;41:56–71.PubMedGoogle Scholar
  39. 39.
    MacGlashan DW Jr, Mogowski M, Lichtenstein LM. Studies of antigen binding on human basophils. II. Continued expression of antigen-specific IgE during antigen-induced desensitization. J Immunol 1983;130:2337–2342.PubMedGoogle Scholar
  40. 40.
    Kazimierczak W, Meier HL, MacGlashan DW Jr, Lichtenstein LM. An antigen-activated DFP-inhibitable enzyme controls basophil desensitization. J Immunol 1984;132:399–405.PubMedGoogle Scholar
  41. 41.
    Jouvin MH, Adamczewski M, Numerof R, Letourneur O, Valle A, Kinet JP. Differential control of the tyrosine kinase lyn and syk by the two signaling chains of the high affinity immunoglobulin E receptor. J Biol Chem 1994;269:5918–5925.PubMedGoogle Scholar
  42. 42.
    Benhamou M, Gutkind JS, Robbins KC, Siraganian RP. Tyrosine phosphorylation coupled to IgE receptor-mediated signal transduction and histamine release. Proc Natl Acad Sci U S A 1990;87:5327–5330.PubMedGoogle Scholar
  43. 43.
    Benhamou M, Stephan V, Gutkind SJ, Robbins KC, Siraganian RP. Protein tyrosine phosphorylation in the degranulation step of RBL-2H3 cells. FASEB J 1991;5:A1007.Google Scholar
  44. 44.
    Eiseman E, Bolen JB. Engagement of the high-affinity IgE receptor activates src protein-related tyrosine kinases. Nature (Lond) 1992;355:78–80.Google Scholar
  45. 45.
    Yamashita T, Mao SY, Metzger H. Aggregation of the high-affinity IgE receptor and enhanced activity of p53/56lyn protein-tyrosine kinase. Proc Natl Acad Sci USA 1994;91:11251–11255.PubMedGoogle Scholar
  46. 46.
    Dembo M, Goldstein B, Sobotka AK, Lichtenstein LM. Degranulation of human basophils: quantitative analysis of histamine release and desensitization, due to a bivalent penicilloyl hapten. J Immunol 1979;123:1864–1872.PubMedGoogle Scholar
  47. 47.
    Sagi-Eisenberg R, Lieman H, Pecht I. Protein kinase C regulation of the receptor-coupled calcium signal in histamine-secreting rat basophilic leukaemia cells. Nature (Lond) 1985;313:59–60.Google Scholar
  48. 48.
    Ozawa K, Yamada K, Kanzanietz MG, Blumberg PM, Beaven MA. Different isozymes of protein kinase C mediate feedback inhibition of phospholipase C and stimulatory signals for exocytosis in rat RBL-2H3 cells. J Biol Chem 1993;268:2280–2283.PubMedGoogle Scholar
  49. 49.
    Ozawa K, Szallasi Z, Kanzanietz MG, et al. Ca2+-dependent and Ca2+-independent isozymes of protein kinase C mediate exocytosis in antigen-stimulated rat basophilic RBL-2H3 cells: Reconstitution of secretory responses with Ca2+ and purified isozymes in washed permeabilized cells. J Biol Chem 1993;268:1749–1756.PubMedGoogle Scholar
  50. 50.
    Lewin I, Jacob-Hirsch J, Zang ZC, et al. Aggregation of the Fc epsilon RI in mast cells induces the synthesis of Fos-interacting protein and increases its DNA binding-activity: the dependence on protein kinase C-beta. J Biol Chem 1996;271:1514–1519.PubMedGoogle Scholar
  51. 51.
    Razin E, Szallasi Z, Kazanietz MG, Blumberg PM, Rivera J. Protein kinases C-beta and C-epsilon link the mast cell high-affinity receptor for IgE to the expression of c-fos and c-jun. Proc Natl Acad Sci U S A 1994;91:7722–7726.PubMedGoogle Scholar
  52. 52.
    Lewin I, Nechushtan H, Ke Q, Razin E. Regulation of AP-1 expression and activity in antigen-stimulated mast cells: the role played by protein kinase C and the possible involvement of Fos interacting protein. Blood 1993;82:3745–3751.PubMedGoogle Scholar
  53. 53.
    Wolfe PC, Chang EY, Rivera J, Fewtrell C. Differential effects of the protein kinase C activator phorbol 12-myristate 13-acetate on calcium responses and secretion in adherent and suspended RBL-2H3 mucosal mast cells. J Biol Chem 1996;271:6658–6665.PubMedGoogle Scholar
  54. 54.
    Szallasi Z, Denning MF, Chang EY, et al. Development of a rapid approach to identification of tyrosine phosphorylation sites: application to PKC delta phosphorylated upon activation of the high affinity receptor for IgE in rat basophilic leukemia cells. Biochem Biophys Res Commun 1995;214:888–894.PubMedGoogle Scholar
  55. 55.
    Ozawa K, Szallasi Z, Blumberg PM, Beaven MA. The role of Ca2+-independent isozymes of protein kinase C (PKC) in exocytosis in antigen-stimulated rat basophil RBL-2H3 cells. FASEB J 1992;6:A1633.Google Scholar
  56. 56.
    Miura K, MacGlashan DW Jr. Expression of Protein Kinase C Isozymes in Human Basophils: Regulation by Physiological and Non-physiological Stimuli. Blood 1998;92:1206–1218.PubMedGoogle Scholar
  57. 57.
    Devalia V, Thomas SB, Roberts PJ, Jones M, Linch DC. Down-regulation of human protein kinase C alpha is associated with terminal neutrophil differentiation. Blood 1992;80:68–76.PubMedGoogle Scholar
  58. 58.
    Dang PM, Rais S, Hakim J, Perianin A. Redistribution of protein kinase C isoforms in human neutrophils stimulated by formyl peptides and phorbol myristate acetate. Biochem Biophys Res Commun 1995;212:664–672.PubMedGoogle Scholar
  59. 59.
    Bates ME, Bertics PJ, Calhoun WJ, Busse WW. Increased protein kinase C activity in low density eosinophils. J Immunol 1993;150:4486–4493.PubMedGoogle Scholar
  60. 60.
    Schleimer RP, Gillespie E, Lichtenstein LM. Release of histamine from human leukocytes stimulated with the tumor promoting phorbol esters. I. Characterization of the response. J Immunol 1981;126:570–574.PubMedGoogle Scholar
  61. 61.
    Kishimoto A, Takei Y, Mori T, Kikkawa U, Nishizuka Y. Activation of calcium and phospholipid dependent protein kinase by diacylglycerol, its possible relation to phosphatidylinositol turnover. J Biol Chem 1983;255:2273.Google Scholar
  62. 62.
    Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, Nishizuka Y. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 1982;257:7847–7853.PubMedGoogle Scholar
  63. 63.
    Warner JA, MacGlashan DW Jr. Protein kinase C (PKC) changes in human basophils. IgE-mediated activation is accompanied by an increase in total PKC activity. J Immunol 1989;142:1669–1677.PubMedGoogle Scholar
  64. 64.
    Lin-Ling L, Wartmann M, Lin AY, Knopf JL, Seth A, Davis RJ. cPLA2 is phosphorylated and activated by MAP kinase. Cell 1993;72:269–278.Google Scholar
  65. 65.
    Nalefski EA, Sultzman LA, Martin DM. Delineation of two functionally distinct domains of cytosolic phospholipase A2, a regulatory Ca-dependent lipid binding domain and a Ca-independent catalytic domain. J Biol Chem 1994;269:18239–18249.PubMedGoogle Scholar
  66. 66.
    Channon JY, Leslie CC. A calcium-dependent mechanism for associating a soluble arachidonoyl-hydrolyzing phospholipase A with membrane in the macrophage cell line RAW 264.7. J Biol Chem 1990;265:5409–5413.PubMedGoogle Scholar
  67. 67.
    Miura K, Hubbard WC, MacGlashan DW, Jr. Phosphorylation of cytosolic PLA2 (cPLA2) by Interleukin-3 (IL-3) is associated with increased free arachidonic acid and LTC4 release in human basophils. J Allergy Clin Immunol 1998;102:512–520.PubMedGoogle Scholar
  68. 68.
    Casolaro V, Georas S, Song Z, et al. Inhibition of NFATp-dependent transcription by NFkB. Implications for differential gene expression in T cell subsets. Proc Natl Acad Sci USA 1995;92:11623–11626.PubMedGoogle Scholar
  69. 69.
    Hirai K, Morita Y, Misaki Y, et al. Modulation of human basophil histamine release by hematopoetic growth factors. J Immunol 1988;141:3957–3961.Google Scholar
  70. 70.
    Hirai K, Yamaguchi M, Misaki Y, et al. Enhancement of human basophil histamine release by interleukin 5. J Exp Med 1990;172:1525–1528.PubMedGoogle Scholar
  71. 71.
    Bischoff SC, de Weck AL, Dahinden CA. Interleukin 3 and granulocyte/macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component C3a. Proc Natl Acad Sci U S A 1990;87:6813–6817.PubMedGoogle Scholar
  72. 72.
    Bischoff SC, Brunner T, De WAL, Dahinden CA. Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists. J Exp Med 1990;172:1577–1582.PubMedGoogle Scholar
  73. 73.
    Schleimer RP, Derse CP, Friedman B, et al. Regulation of human basophil mediator release by cytokines. I. Interaction with antiinflammatory steroids. J Immunol 1989;143:1310–1317.PubMedGoogle Scholar
  74. 74.
    Massey WA, Randall TC, Kagey SA, et al. Recombinant human IL-1 alpha and -1 beta potentiate IgE-mediated histamine release from human basophils. J Immunol 1989;143:1875–1880.PubMedGoogle Scholar
  75. 75.
    Pazdrak K, Stafford S, Alam R. The activation of the Jak-STAT 1 signaling pathway by IL-5 in eosinophils. J Immunol 1995;155:397–402.PubMedGoogle Scholar
  76. 76.
    Ihle JN, Kerr IM. Jaks and Stats in signaling by the cytokine receptor superfamily. [Review]. Trends Genet 1995;11:69–74.PubMedGoogle Scholar
  77. 77.
    Bochner BS, Mckelvey AA, Sterbinsky SA, et al. IL-3 augments adhesiveness for endothelium and Cd11B expression in human basophils but not neutrophils. J Immunol 1990;145:1832–1837.PubMedGoogle Scholar
  78. 78.
    Yamaguchi M, Hirai K, Ohta K, et al. Culturing in the presence of IL-3 converts anti-IgE nonresponding basophils into responding basophils. J Allergy Clin Immunol 1996;97:1279–1287.PubMedGoogle Scholar
  79. 79.
    Schleimer RP, Lichtenstein LM, Gillespie E. Inhibition of basophil histamine release by anti-inflammatory steroids. Nature (Lond) 1981;292:454–455.Google Scholar
  80. 80.
    Schleimer RP, Schulman ES, MacGlashan DW Jr, et al. Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells. J Clin Invest 1983;71:1830–1835.PubMedGoogle Scholar
  81. 81.
    Schleimer RP, MacGlashan DW Jr, Gillespie E, Lichtenstein LM. Inhibition of basophil histamine release by anti-inflammatory steroids. II. Studies on the mechanism of action. J Immunol 1982;129:1632–1636.PubMedGoogle Scholar
  82. 82.
    Stellato C, Lichtenstein LM, MacGlashan DW Jr, Schleimer RP. Dexamethasone selectively inhibits IL-3 priming of basophil C5a responses. J Allergy Clin Immunol 1991;87:72a.Google Scholar
  83. 83.
    Cirillo R, Triggiani M, Siri L, et al. Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin. J Immunol 1990;144:3891–3897.PubMedGoogle Scholar
  84. 84.
    Schroeder JT, MacGlashan DW Jr, MacDonald SM, Kagey-Sobotka A, Lichtenstein LM. Regulation of IgE-dependent IL-4 generation by human basophils treated with glucocorticosteroids. J Immunol 1997; (in press).Google Scholar
  85. 85.
    Lichtenstein LM, Margolis S. Histamine release in vitro: inhibition by catecholamines and methylxanthines. Science 1968;161:902–903.PubMedGoogle Scholar
  86. 86.
    Bourne HR, Lichtenstein LM, Melmon KL, Henney CS, Weinstein Y, Shearer GM. Modulation of inflammation and immunity by cyclic AMP. Science 1974;184:19.PubMedGoogle Scholar
  87. 87.
    Lichtenstein LM, Gillespie E. Inhibition of histamine release by histamine controlled by H2 receptor. Nature (Lond) 1973;244:287–288.Google Scholar
  88. 88.
    Gillespie E, Lichtenstein LM. Histamine release from human leukocytes: relationships between cyclic nucleotide, calcium, and antigen concentrations. J Immunol 1975;115:1572–1576.PubMedGoogle Scholar
  89. 89.
    Peachell PT, MacGlashan DW Jr, Lichtenstein LM, Schleimer RP. Regulation of human basophil and lung mast cell function by cyclic adenosine monophosphate. J Immunol 1988;140:571–579.PubMedGoogle Scholar
  90. 90.
    Peachell PT, Undem BJ, Schleimer RP, et al. Preliminary identification and role of phosphodiesterase isozymes in human basophils. J Immunol 1992;148:2503–2510.PubMedGoogle Scholar
  91. 91.
    Tung R, Kagey SA, Plaut M, Lichtenstein LM. H2 antihistamines augment antigen-induced histamine release from human basophils in vitro. J Immunol 1982;129:2113–2115.PubMedGoogle Scholar
  92. 92.
    Botana LM, MacGlashan DW Jr. Differential effects of cAMP on mediator release in human basophils. FASEB J 1991;5:A1007.Google Scholar
  93. 93.
    Putney JW. A model for receptor-regulated calcium entry. Cell Calcium 1986;7:1–12.PubMedGoogle Scholar
  94. 94.
    Choi OH, Kim JH, Kinet JP. Calcium mobilization via sphingosine kinase in signaling by the FcεRI antigen receptor. Nature (Lond) 1996;380:634–636.Google Scholar
  95. 95.
    Malveaux FJ, Conroy MC, Adkinson NFJ, Lichtenstein LM. IgE receptors on human basophils. Relationship to serum IgE concentration. J Clin Invest 1978;62:176–181.PubMedGoogle Scholar
  96. 96.
    Hsu C, MacGlashan DW Jr. IgE Antibody up-regulates high affinity IgE binding on murine bone marrow derived mast cells. Immunol Lett 1996;52:129–134.PubMedGoogle Scholar
  97. 97.
    Lantz CS, Yamaguchi M, Oettgen HC, et al. IgE regulates mouse basophil FcεRI expression in vivo. J Immunol 1997;158:2517–2521.PubMedGoogle Scholar
  98. 98.
    Yamaguchi M, Lantz CS, Oettgen HC, et al. IgE enhances mouse mast cell FcεRI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions. J Exp Med 1997;185:663–672.PubMedGoogle Scholar
  99. 99.
    MacGlashan DW Jr, Bochner BS, Adelman DC, et al. Down-regulation of FcεRI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol 1997;158:1438–1445.PubMedGoogle Scholar
  100. 100.
    MacGlashan DW Jr, White-Mckenzie J, Chichester K, et al. In vitro regulation of FcεRIa expression on human basophils by IgE antibody. Blood 1998;91:1633–1643.PubMedGoogle Scholar
  101. 101.
    Lee WT, Conrad DH. Murine B cell hybridomas bearing ligand-inducible Fc receptors for IgE. J Immunol 1986;136:4573–4580.PubMedGoogle Scholar
  102. 102.
    Lee WT, Rao M, Conrad DH. The murine lymphocyte receptor for IgE. IV. The mechanism of ligand-specific receptor upregulation on B cells. J Immunol 1987;139:1191–1198.PubMedGoogle Scholar
  103. 103.
    Schroeder JT, Howard BP, Jenkens MK, Kagey-Sobotka A, Lichtenstein LM, MacGlashan DW Jr. IL-4 secretion and histamine release by human basophils are differentially regulated by protein kinase C activation. J Leukoc Biol 1998;63:692–698.PubMedGoogle Scholar
  104. 104.
    Hundley TR, Marshall L, Hubbard WC, MacGlashan DW Jr. Characteristics of arachidonic acid generation in human basophils: Relationship between the effects of inhibitors of secretory phospholipase A2 activity and leukotriene C4 release. J Pharm Exp Ther 1998;284:847–857.Google Scholar

Copyright information

© Springer-Verlag New York, Inc. 1999

Authors and Affiliations

  • Donald MacGlashanJr.

There are no affiliations available

Personalised recommendations